to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
With medical device companies becoming increasingly frustrated with the U.S. Food and Drug Administration, many American companies are looking to Europe to get approval there first. Here are some tips to consider before pursuing the CE Mark.
Venture firms are approaching angel investor groups to co-invest at the growth stage of startups. Read more about the impact this could have on startup health IT companies.
Medical foundations play a role in helping medicine advance through their philanthropy, but sometimes even the most well-intentioned of them can lose their way. Read more about how these foundations can stay focused on their goals.
Biotech companies that work with healthcare payers can get a better sense of the kinds of innovations that are most in demand. Read more about how working with payers can give innovators an edge.
Should the U.S. Food and Drug Administration protect the public or drive innovation? One industry leader gives us his take on the future of the FDA.
In biotech research, the gathering and analysis of data takes a great deal of time. With portable legal consent, Sage Bionetworks aims to reduce data collection time for researchers so they can make their discoveries earlier.
The Chief Academic Officer of the Center for Integration of MedicineĀ and Innovative Technology urges busy doctors not to ignore the ideas they have for improving medicine.
Panelists at the Partnering for Cures conference agreed that straightening out the economy here and abroad would go a long way toward making research dollars available to advance biomedical research. However, until economic conditions improve, it's hard to say how biomedical startups will fare.
This week, eMed will be providing coverage of Partnering for Cures, a conference bringing together leaders in biotech research to discuss the healthcare business landscape.
The U.S. Food and Drug Administration's laborious and lengthy approval process is hitting healthcare business owners in the pocketbook. But the FDA could be hitting consumers worse.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.